In a significant regulatory overhaul aimed at streamlining administrative workflows and enhancing transparency, the Central Drugs Standard Control Organization (CDSCO) has announced the implementation of an automated re-application process for the issuance of Compliance Certificates (CoCs) for medical device manufacturers. This initiative is set to
Axis Securities Report Highlights Positive Trends for Q2 FY25The Indian pharmaceutical industry is poised for a robust year, with revenue growth projected at 8.5% year-on-year (YoY) for the second quarter of FY25, driven primarily by domestic formulations and strategic niche launches in the US market.
Villagers come together to raise funds to take care of the patient's medical expensesAs Rakhi festivities were celebrated all over the country, a 21-year-old sister went above and beyond for her 17-year-old brother who was battling autoimmune liver cirrhosis. By offering her own portion of
New Medical Device Bill, 2023 will prove catastrophic for domestic players: Rajiv Nath The New Drugs, Medical Devices and Cosmetics Bill, 2023 is fraught with loopholes and repercussions for domestic medical device industry and must be recalled for further deliberations and corrections failing which Prime
According to a study published in the Lancet on Friday, the COVID-19 pandemic led to a surge in anxiety and major depressive disorders across the world, particularly among women and young people. The researchers said, children suffered as school closures kept them away from friends, and
